نتائج البحث

What factors may affect the effect of ICI-combined therapy in patients with metastatic renal cell carcinoma? A meta-analysis.

• Authors : Yan, Haiyang^1,2 (AUTHOR); Xing, Zhaohui³ (AUTHOR); Liu, Shuai⁴ (AUTHOR)

• Source: Immunopharmacology & Immunotoxicology. Jun2024, Vol. 46 Issue 3, p302-318. 17p.

تفاصيل العنوان

The Survival Outcomes of the Metastatic Nonclear Cell Renal Cell Carcinoma in the Immunotherapy Era: Princess Margaret Cancer Centre Experience.

• Authors : Al-Ezzi, Esmail¹; Mittal, Abhenil¹; Veitch, Zachary W.²

• Source: Journal of Kidney Cancer & VHL. 2024, Vol. 11 Issue 1, p41-48. 8p.

تفاصيل العنوان

Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement.

• Authors : Lalani, Aly-Khan A.¹ ; Kapoor, Anil²; Basappa, Naveen S.³

• Source: Canadian Urological Association Journal. May2023, Vol. 17 Issue 5, pE154-E163. 10p.

تفاصيل العنوان

2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma.

• Authors : Graham, Jeffrey¹; Ahmad, Ardalan E.²; Basappa, Naveen S.³

• Source: Canadian Urological Association Journal. Nov2024, Vol. 18 Issue 11, pE371-E386. 16p.

تفاصيل العنوان

Disparity in public funding of systemic therapy for metastatic renal cell carcinoma in Canada.

• Authors : Jackson, Emily B.¹ ; Hotte, Sebastien J.²

• Source: Canadian Urological Association Journal. Nov2022, Vol. 16 Issue 11, pE516-E522. 7p.

تفاصيل العنوان

Use of targeted therapy in patients with metastatic renal cell carcinoma: clinical and economic impact in a Canadian real-life setting.

• Authors : Nazha, S.¹; Tanguay, S.¹; Kapoor, A.²

• Source: Current Oncology. Dec2018, Vol. 25 Issue 6, pe576-e584. 9p.

تفاصيل العنوان

Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma.

• Authors : Mason, Ross J.¹; Wood, Lori²; Kapoor, Anil³

• Source: Canadian Urological Association Journal. Jun2019, Vol. 13 Issue 6, p166-174. 9p.

تفاصيل العنوان

Positive surgical margins during partial nephrectomy for renal cell carcinoma: Results from Canadian Kidney Cancer information system (CKCis) collaborative.

• Authors : Bansal, Rahul K.¹; Tanguay, Simon²; Finelli, Antonio³

• Source: Canadian Urological Association Journal. Jun2017, Vol. 11 Issue 6, p182-187. 6p.

تفاصيل العنوان

Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database.

• Authors : Park CL; McGill University Health Centre, McGill University, Montreal, QC H4A 3J1, Canada.; Moria FA

Subjects: Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/mortality ; Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/surgery ; Nephrectomy*/Nephrectomy*/Nephrectomy*/methods

• Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Aug 18; Vol. 31 (8), pp. 4704-4712. Date of Electronic Publication: 2024 Aug 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729

تفاصيل العنوان

How Do Cost-Effectiveness Analyses Inform Reimbursement Decisions for Oncology Medicines in Canada? The Example of Sunitinib for First-Line Treatment of Metastatic Renal Cell Carcinoma.

• Authors : Chabot, Isabelle¹ ; Rocchi, Angela²

• Source: Value in Health. Sep/Oct2010, Vol. 13 Issue 6, p837-845. 9p.

تفاصيل العنوان